Treating allergic airway disorders using anti-IL-20 receptor antibodies

Ming-Shi Chang (Inventor)

Research output: Patent

Abstract

Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.
Original languageEnglish
Patent number8852588
Publication statusPublished - 1800

Fingerprint

Airway Obstruction
Asthma
Antibodies
interleukin-20 receptor

Cite this

@misc{c4510d3295fb433f865d9105a621837e,
title = "Treating allergic airway disorders using anti-IL-20 receptor antibodies",
abstract = "Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.",
author = "Ming-Shi Chang",
year = "1800",
language = "English",
type = "Patent",
note = "8852588",

}

TY - PAT

T1 - Treating allergic airway disorders using anti-IL-20 receptor antibodies

AU - Chang, Ming-Shi

PY - 1800

Y1 - 1800

N2 - Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.

AB - Treatment of an allergic airway disorder (e.g., asthma or bronchial airway obstruction) using anti-IL-20R1 antibodies such as mAb51D, mAb7GW, or functional variants thereof.

M3 - Patent

M1 - 8852588

ER -